Annual CFF
$24.49 M
+$22.19 M+964.49%
June 30, 2024
Summary
- As of February 8, 2025, IBIO annual cash flow from financing activities is $24.49 million, with the most recent change of +$22.19 million (+964.49%) on June 30, 2024.
- During the last 3 years, IBIO annual CFF has fallen by -$54.34 million (-68.93%).
- IBIO annual CFF is now -68.93% below its all-time high of $78.83 million, reached on June 30, 2021.
Performance
IBIO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$162.00 K
-$13.15 M-101.25%
September 30, 2024
Summary
- As of February 8, 2025, IBIO quarterly cash flow from financing activities is -$162.00 thousand, with the most recent change of -$13.15 million (-101.25%) on September 30, 2024.
- Over the past year, IBIO quarterly CFF has dropped by -$13.15 million (-101.25%).
- IBIO quarterly CFF is now -100.33% below its all-time high of $49.76 million, reached on June 30, 2020.
Performance
IBIO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$21.86 M
-$2.63 M-10.75%
September 30, 2024
Summary
- As of February 8, 2025, IBIO TTM cash flow from financing activities is $21.86 million, with the most recent change of -$2.63 million (-10.75%) on September 30, 2024.
- Over the past year, IBIO TTM CFF has dropped by -$2.63 million (-10.75%).
- IBIO TTM CFF is now -83.34% below its all-time high of $131.23 million, reached on December 31, 2020.
Performance
IBIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IBIO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +964.5% | -101.3% | -10.8% |
| 3 y3 years | -68.9% | -111.1% | +4968.6% |
| 5 y5 years | +609.4% | -111.1% | +4968.6% |
IBIO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.9% | +499.9% | -101.3% | +97.3% | -10.8% | +456.9% |
| 5 y | 5-year | -68.9% | +499.9% | -100.3% | +97.3% | -83.3% | +456.9% |
| alltime | all time | -68.9% | +499.9% | -100.3% | +97.3% | -83.3% | +456.9% |
IBio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$162.00 K(-101.2%) | $21.86 M(-10.8%) |
| Jun 2024 | $24.49 M(+964.5%) | $12.99 M(+158.5%) | $24.49 M(+72.0%) |
| Mar 2024 | - | $5.03 M(+25.5%) | $14.24 M(+33.3%) |
| Dec 2023 | - | $4.00 M(+62.0%) | $10.68 M(+194.1%) |
| Sep 2023 | - | $2.47 M(-9.8%) | $3.63 M(+57.8%) |
| Jun 2023 | $2.30 M(-137.6%) | $2.74 M(+87.2%) | $2.30 M(-612.5%) |
| Mar 2023 | - | $1.46 M(-148.1%) | -$449.00 K(-76.7%) |
| Dec 2022 | - | -$3.04 M(-366.8%) | -$1.92 M(-60.7%) |
| Sep 2022 | - | $1.14 M(<-9900.0%) | -$4.90 M(-20.1%) |
| Jun 2022 | -$6.13 M(-107.8%) | -$10.00 K(0.0%) | -$6.13 M(+91.2%) |
| Mar 2022 | - | -$10.00 K(-99.8%) | -$3.20 M(-307.3%) |
| Dec 2021 | - | -$6.02 M(+6737.5%) | $1.54 M(-96.4%) |
| Sep 2021 | - | -$88.00 K(-103.0%) | $42.65 M(-45.9%) |
| Jun 2021 | $78.83 M(+20.9%) | $2.91 M(-38.5%) | $78.83 M(-37.3%) |
| Mar 2021 | - | $4.74 M(-86.5%) | $125.68 M(-4.2%) |
| Dec 2020 | - | $35.08 M(-2.8%) | $131.23 M(+29.6%) |
| Sep 2020 | - | $36.10 M(-27.4%) | $101.29 M(+55.4%) |
| Jun 2020 | $65.19 M(+1788.0%) | $49.76 M(+383.7%) | $65.19 M(+323.8%) |
| Mar 2020 | - | $10.29 M(+99.9%) | $15.38 M(+204.9%) |
| Dec 2019 | - | $5.15 M(>+9900.0%) | $5.05 M(+118.4%) |
| Sep 2019 | - | $0.00(-100.0%) | $2.31 M(-33.1%) |
| Jun 2019 | $3.45 M(-84.6%) | -$50.00 K(0.0%) | $3.45 M(-82.5%) |
| Mar 2019 | - | -$50.00 K(-102.1%) | $19.70 M(-0.6%) |
| Dec 2018 | - | $2.41 M(+110.8%) | $19.82 M(-12.3%) |
| Sep 2018 | - | $1.14 M(-92.9%) | $22.59 M(+0.8%) |
| Jun 2018 | $22.41 M(<-9900.0%) | $16.19 M(>+9900.0%) | $22.41 M(+263.1%) |
| Mar 2018 | - | $75.00 K(-98.6%) | $6.17 M(+1.9%) |
| Dec 2017 | - | $5.18 M(+442.2%) | $6.05 M(+631.8%) |
| Sep 2017 | - | $956.00 K(-2272.7%) | $827.00 K(-586.5%) |
| Jun 2017 | -$170.00 K(-100.8%) | -$44.00 K(+2.3%) | -$170.00 K(-104.4%) |
| Mar 2017 | - | -$43.00 K(+2.4%) | $3.88 M(-82.0%) |
| Dec 2016 | - | -$42.00 K(+2.4%) | $21.52 M(-0.2%) |
| Sep 2016 | - | -$41.00 K(-101.0%) | $21.56 M(-0.5%) |
| Jun 2016 | $21.66 M | $4.00 M(-77.3%) | $21.66 M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $17.60 M(>+9900.0%) | $20.36 M(+319.7%) |
| Dec 2015 | - | $0.00(-100.0%) | $4.85 M(-53.5%) |
| Sep 2015 | - | $63.00 K(-97.7%) | $10.43 M(-4.0%) |
| Jun 2015 | $10.87 M(+206.0%) | $2.70 M(+29.1%) | $10.87 M(+33.0%) |
| Mar 2015 | - | $2.09 M(-62.5%) | $8.17 M(+34.4%) |
| Dec 2014 | - | $5.58 M(+1015.8%) | $6.08 M(+50.1%) |
| Sep 2014 | - | $500.00 K(>+9900.0%) | $4.05 M(+14.1%) |
| Jun 2014 | $3.55 M(-7.4%) | $0.00(0.0%) | $3.55 M(-51.9%) |
| Mar 2014 | - | $0.00(-100.0%) | $7.38 M(0.0%) |
| Dec 2013 | - | $3.55 M(>+9900.0%) | $7.38 M(+92.6%) |
| Sep 2013 | - | $0.00(-100.0%) | $3.83 M(0.0%) |
| Jun 2013 | $3.83 M(-57.6%) | $3.83 M(>+9900.0%) | $3.83 M(>+9900.0%) |
| Mar 2013 | - | $0.00(0.0%) | $200.00(-100.0%) |
| Dec 2012 | - | $0.00(-100.0%) | $9.12 M(+0.9%) |
| Jun 2012 | $9.04 M(+22.7%) | $200.00(-100.0%) | $9.04 M(+0.0%) |
| Mar 2012 | - | $9.12 M(<-9900.0%) | $9.04 M(>+9900.0%) |
| Dec 2011 | - | -$85.30 K(<-9900.0%) | $44.70 K(-99.4%) |
| Sep 2011 | - | $0.00(0.0%) | $7.37 M(0.0%) |
| Jun 2011 | $7.37 M(+163.4%) | $0.00(-100.0%) | $7.37 M(0.0%) |
| Mar 2011 | - | $130.00 K(-98.2%) | $7.37 M(+1.8%) |
| Dec 2010 | - | $7.24 M(>+9900.0%) | $7.23 M(+158.7%) |
| Jun 2010 | $2.80 M(-40.0%) | $0.00(-100.0%) | $2.80 M(0.0%) |
| Mar 2010 | - | -$1600.00(-83.3%) | $2.80 M(-0.1%) |
| Dec 2009 | - | -$9600.00(-100.3%) | $2.80 M(-0.3%) |
| Sep 2009 | - | $2.81 M(>+9900.0%) | $2.81 M(-39.8%) |
| Jun 2009 | $4.66 M(+224.4%) | $0.00(0.0%) | $4.66 M(-5.0%) |
| Mar 2009 | - | $0.00(0.0%) | $4.91 M(-8.1%) |
| Dec 2008 | - | $0.00(-100.0%) | $5.34 M(-4.8%) |
| Sep 2008 | - | $4.66 M(+1803.8%) | $5.61 M(+290.0%) |
| Jun 2008 | $1.44 M(-25.4%) | $244.90 K(-43.3%) | $1.44 M(+20.5%) |
| Mar 2008 | - | $432.10 K(+62.3%) | $1.19 M(+56.8%) |
| Dec 2007 | - | $266.30 K(-46.1%) | $760.30 K(+53.9%) |
| Sep 2007 | - | $494.00 K | $494.00 K |
| Jun 2007 | $1.93 M | - | - |
FAQ
- What is iBio annual cash flow from financing activities?
- What is the all time high annual CFF for iBio?
- What is iBio annual CFF year-on-year change?
- What is iBio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for iBio?
- What is iBio quarterly CFF year-on-year change?
- What is iBio TTM cash flow from financing activities?
- What is the all time high TTM CFF for iBio?
- What is iBio TTM CFF year-on-year change?
What is iBio annual cash flow from financing activities?
The current annual CFF of IBIO is $24.49 M
What is the all time high annual CFF for iBio?
iBio all-time high annual cash flow from financing activities is $78.83 M
What is iBio annual CFF year-on-year change?
Over the past year, IBIO annual cash flow from financing activities has changed by +$22.19 M (+964.49%)
What is iBio quarterly cash flow from financing activities?
The current quarterly CFF of IBIO is -$162.00 K
What is the all time high quarterly CFF for iBio?
iBio all-time high quarterly cash flow from financing activities is $49.76 M
What is iBio quarterly CFF year-on-year change?
Over the past year, IBIO quarterly cash flow from financing activities has changed by -$13.15 M (-101.25%)
What is iBio TTM cash flow from financing activities?
The current TTM CFF of IBIO is $21.86 M
What is the all time high TTM CFF for iBio?
iBio all-time high TTM cash flow from financing activities is $131.23 M
What is iBio TTM CFF year-on-year change?
Over the past year, IBIO TTM cash flow from financing activities has changed by -$2.63 M (-10.75%)